Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933841 · ClinicalTrials.gov registry record
The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 201
- Enrollment target
NCT01933841 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 201 participants.
The verdict
NCT01933841 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
Neuromuscular blocking drugs (NMBDs) provide anesthesiologists with powerful intraoperative tools, but their use carries the potential risk of serious postoperative complications. NMBD-induced muscle weakness that lingers into the postoperative period, known as postoperative residual curarization (PORC), is present in as many as 40% of all patients that receive neuromuscular blocking agents. The Post Anesthesia Care Unit will be introducing monitoring as part of standard of care. This study will collect data about patients who receive NMBDs and examine the impact of monitoring on incidences of PORC. Our study is designed to test the following hypotheses: Hypothesis 1: The initiation of quantitative TOF monitoring as part of the standard PACU entry evaluation will change practitioner behavior in a manner that decreases the incidence of PORC in surgical patients at VUMC. Hypothesis 2: The initiation of the routine TOF monitoring program will decrease the incidence of short- and long-term postoperative complications at VUMC.
Interventions
- DEVICE TOF-Watch SX
- PROCEDURE Notify the provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01933841
The ClinicalTrials.gov registry entry for NCT01933841 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TOF-Watch SX is the first listed.
NCT01933841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01933841 about?
NCT01933841 is a clinical study titled "The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery". Neuromuscular blocking drugs (NMBDs) provide anesthesiologists with powerful intraoperative tools, but their use carries the potential risk of serious postoperative complications. NMBD-induced muscle weakness that lingers into the postoperative period, known as postoperative residual curarization (P...
What is the current status of trial NCT01933841?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2016-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01933841?
The interventions under investigation include: TOF-Watch SX (DEVICE), Notify the provider (PROCEDURE).
Who is sponsoring clinical trial NCT01933841?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.